Work

Neoadjuvant low-dose carboplatin and docetaxel in combination with toripalimab for early or locally advanced triple-negative breast cancer (NeoTOP): A single-arm phase 2 trial.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.589

Authors: Jun Tang, Ning Li, Tian Du, Yan Wang, Hao Wu, Gehao Liang, Zixuan Zhao, Xinhua Xie, Jin Wang, Yanan Kong, Peng Liu, Zeyu Shuang

Institution: Sun Yat-sen University Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410809201

Cites:

Cited by:

Related to: 10